KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Inventory (2016 - 2026)

Medtronic (MDT) has disclosed Inventory for 13 consecutive years, with $6.3 billion as the latest value for Q1 2026.

  • Quarterly Inventory rose 12.46% to $6.3 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.3 billion through Jan 2026, up 12.46% year-over-year, with the annual reading at $5.5 billion for FY2025, 4.96% up from the prior year.
  • Inventory hit $6.3 billion in Q1 2026 for Medtronic, up from $6.2 billion in the prior quarter.
  • In the past five years, Inventory ranged from a high of $6.3 billion in Q1 2026 to a low of $4.5 billion in Q1 2022.
  • Historically, Inventory has averaged $5.4 billion across 5 years, with a median of $5.5 billion in 2025.
  • Biggest five-year swings in Inventory: increased 19.07% in 2023 and later dropped 4.78% in 2024.
  • Year by year, Inventory stood at $5.1 billion in 2022, then increased by 13.83% to $5.8 billion in 2023, then decreased by 4.78% to $5.5 billion in 2024, then grew by 12.36% to $6.2 billion in 2025, then grew by 2.49% to $6.3 billion in 2026.
  • Business Quant data shows Inventory for MDT at $6.3 billion in Q1 2026, $6.2 billion in Q4 2025, and $5.9 billion in Q3 2025.